Results 1 to 10 of about 126,525 (327)
World Journal of Surgical Oncology, 2022 Objective To systematically evaluate the relationship between vascular endothelial growth factor (VEGF) and prognosis of intrahepatic cholangiocarcinoma by meta-analysis.
Chunping Cai +3 more
doaj +2 more sources
BMC Cancer, 2021 Background Cholangiocarcinoma is a common malignant tumor of digestive system. LncRNA metallothionein 1 J, pseudogene (MT1JP) has been reported to play tumor-suppressing roles in multiple cancers.
Wei Zhao +5 more
doaj +2 more sources
Intrahepatic cholangiocarcinoma [PDF]
Вестник рентгенологии и радиологии, 2016 The paper gives information on current approaches to diagnosing and treating intrahepatic cholangiocarcinoma (IHC), its microscopic and macroscopic varieties. It details the specificfeatures of images of IHC by ultrasonography, X-ray computed tomography,
A. B. Luk’yanchenko +5 more
doaj +3 more sources
Recurrent Intrahepatic Cholangiocarcinoma – Review [PDF]
Frontiers in Oncology, 2021 Intrahepatic cholangiocarcinoma (ICC) is the second-most common primary liver malignancy after hepatocellular carcinoma. While surgical resection with negative margin is the only curative treatment, ICC has very high rate of recurrence, up to 60-70% after curative resection.
Yuki Bekki +5 more
openaire +4 more sources
Management of Intrahepatic Cholangiocarcinoma [PDF]
Journal of Clinical Medicine, 2021 Cholangiocarcinoma is a tumor that arises as a result of differentiation of the cholangiocytes and can develop from anywhere in the biliary tree. Subtypes of cholangiocarcinoma are differentiated based on their location in the biliary tree. If diagnosed early these can be resected, but most cases of intrahepatic cholangiocarcinoma present late in the ...
Sudha Kodali +4 more
openaire +3 more sources
Nature CommunicationsIntratumoral immune status influences tumor therapeutic response, but it remains largely unclear how the status determines therapies for patients with intrahepatic cholangiocarcinoma.
Jia-Cheng Lu +29 more
doaj +2 more sources
Prognostic impact of RPL15 overexpression in intrahepatic cholangiocarcinoma: a marker of aggressive tumor behavior [PDF]
Diagnostic PathologyBackground Overexpression of ribosomal proteins has been found in several cancer types and has an important role in cell proliferation and tumorigenesis. Analysis of the expression profiles of cholangiocarcinoma revealed that ribosomal protein L15 (RPL15)
Wen-Ching Wang +11 more
doaj +2 more sources
Intrahepatic Cholangiocarcinoma [PDF]
Seminars in Interventional Radiology, 2020 AbstractCholangiocarcinoma is the second most common primary malignancy of the liver. This review will focus on the mass-forming intrahepatic type of this disease and discuss the role of medical, surgical, and radiation oncology in managing this difficult disease.
Pouya, Entezari, Ahsun, Riaz
+7 more sources
Intrahepatic Cholangiocarcinoma [PDF]
Surgical Oncology Clinics of North America, 2014 Intrahepatic cholangiocarcinoma (ICC) is a rare tumor, with an increasing incidence worldwide and an overall poor prognosis. Symptoms are usually nonspecific, contributing to an advanced tumor stage at diagnosis. The staging system for ICC has recently been updated and is based on number of lesions, vascular invasion, and lymph node involvement ...
Kimberly M, Brown +2 more
+5 more sources
An extremely rare case of intrahepatic sarcomatoid cholangiocarcinoma
Radiology Case Reports, 2023 One uncommon histological subtype of intrahepatic cholangiocarcinoma is sarcomatoid intrahepatic cholangiocarcinoma. Histopathological and immunohistochemical tests are used to diagnose sarcomatoid intrahepatic cholangiocarcinoma, which frequently has a ...
Dau Quang Lieu, MD +4 more
doaj +1 more source